Ars Technica·5 min read·medium
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
✦AI Summary
Moderna's mRNA-based flu vaccine has received FDA approval for adults aged 50 and older following a unanimous advisory vote. The approval process faced significant political friction due to the current administration's stance on mRNA technology.
Approved Moderna’s mRNA flu shot earns FDA approval after rollercoaster review Moderna’s new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
healthpoliticsscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in